Harmony Clinical Research   Report issue

For profit Phase 1 Phase 2
Founded: North Miami Beach FL United States (2010)

Organization Overview

First Clinical Trial
2019
NCT04055454
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Harmony Clinical Research

Active Ingredients

Drugs in Phase 2 Trials (2)

inactivated influenza vaccine (1 trial)

ovx836 (1 trial)

Drugs in Phase 1 Trials (1)

mv-lasv (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 1)

Lassa Fever (Phase 1)

Virus Diseases (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3